Wellcare requires participating pharmacies to perform a drug utilization review (DUR). This review analyzes drug safety and usage for members based on their profile. The DUR is an important tool that screens on-line real time interactions such as:
- Dagiti Interaksyon nga Agas-ken-Agas
- Proteksyon maipapan ti Agas-Edad
- Proteksyon maipapan ti Agas-Kasarian
- Proteksyon para ti kamali nga dosis
- Madi usto nga kinaatiddog ti drug therapy
- Therapeutic duplication
- Proteksyon para ti sobra nga panagusar
- Dagiti limitasyon ti reseta
- Compliance monitoring
The drug utilization review serves as a measure to ensure drug usage criteria meet and satisfy FDA guidelines. The review also ensures our plan’s Pharmacy and Therapeutic Committee and First Data Bank Criteria adopt clinical protocols. Based on this review, the attending pharmacist and/or physician can make the most beneficial decision to the patient involving their pharmaceutical care.
Panagisigurado ti Kalidad
Wellcare ensures the safety and health of its members through the establishment of effective Quality Assurance measures and systems. We do this to reduce medication errors and adverse drug reactions, and improve medication utilization. These measures include making sure that providers comply with pharmacy practice standards, drug utilization review, internal medication error identification systems, medical therapy management programs, and Pharmacy and Therapeutics Committees. Wellcare also partners with state Quality Improvement Organizations (QIO) that are contracted with Medicare to collect, analyze, and report data based on medication therapy practices.